Back to Journals » OncoTargets and Therapy » Volume 7

FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping

Total article views   HTML views PDF downloads Totals
10,929 Dovepress* 9,610+ 1,287 10,897
PubMed Central* 1,319 494 1,813
Totals 10,929 1,781 12,710
*Since 21 November 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar